ClinicalTrials.gg
CompletedNCT03434782Updated Feb 15, 2018

Effect of Laser and Potassium Nitrate Application on the Sensitivity Control in Bleached Teeth

A Phase 1 interventional study of In-office dental bleaching and Low Level Laser Therapy in Dentin Sensitivity, sponsored by Universidade Federal do Para. Completed at 1 site in Brazil. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-15.

Sponsored by Universidade Federal do Para · Phase 1, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Apr 2017, registered Jan 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 19 studies in Dentin Sensitivity by Universidade Federal do Para — 2 open to participants now, 2 under way, 1 of them phase 3. Dentin Sensitivity · Universidade Federal do Para.

Enrollment
9th of 19
50 · median 50
Started
2017
the only one that year
Phase 1
3 of 19
1 open now
Registered
2nd of 19
by date

Among the 19 studies in Dentin Sensitivity by Universidade Federal do Para, this one is the 9th largest by enrollment, is the only one that started in 2017, is one of 3 in phase 1, and was the 2nd registered.

Dentin Sensitivity

291 studies on the registry are indexed under Dentin Sensitivity; 49 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

2 of the 19 studies in Dentin Sensitivity by Universidade Federal do Para are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 20 Dentin Sensitivity studies recruiting now, 6 (30%) set no upper age limit and 13 (65%) stop at 75 or younger; 2 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Dentin Sensitivity by Universidade Federal do Para, or all of them as a file.
02

Study summary

To investigate the effects of desensitizing agents on the dental bleaching process, testing the hypothesis that they may control dental sensitivity.

Read the detailed description

The objective of this double blind, randomized and controlled clinical study, was to evaluate the efficacy of potassium nitrate / sodium fluoride (KNO3 / KF) gel associated with LLLT (Low Level Light Therapy) on teeth that were exposed to 35% hydrogen peroxide during 3 weeks of bleaching treatment. Methods: 50 volunteers were evaluated through the split-mouth model, where the hemiarcates were randomized and later allocated in one of the experimental groups: G1 (negative control)- group with no desensitizing treatment, only bleached; G2 (positive control)- group treated with LLLT + placebo gel; G3- group treated with placebo laser application + 5% KNO3 / 2% KF gel; and G4- group treated with LLLT + 5% KNO3 / 2% KF gel.

03

Conditions studied

  • Dentin Sensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Absence of active carious lesions;
  • Never undergone bleaching therapy;
  • Good oral hygiene;
  • Do not present ;
  • Do not smoke;
  • Not being pregnant;
  • Presence of at least 28 teeth in oral cavity.

Exclusion criteria

Exclusion Criteria:

  • Presence of periodontal disease;
  • Presence of cracks or fractures;
  • Presence of restorations and prostheses;
  • Presence of gastroesophageal dysfunction;
  • Patients with severe internal dental dimming;
  • Presence of periodontal disease;
  • Presence of dentin exposure in anterior and/or posterior teeth.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    G1- Negative Control

    Group with no desensitizing treatment. Prior to bleaching therapy, a water-soluble placebo gel, with non-active agent will be applied to dental vestibular surfaces. After bleaching therapy, the LASER tip will be positioned in two points (apical and cervical), without light emission (placebo).

    Drug: In-office dental bleaching

  • Experimental
    G2- LASER (Positive Control)

    Group treated with placebo gel before bleaching and with LLLT after in-office bleaching.

    Drug: In-office dental bleaching · Drug: Low Level Laser Therapy

  • Experimental
    G3- KNO3 (Positive Control)

    Group treated with desensitizing gel before bleaching and after in-office bleaching, the LASER tip will be positioned in two points (apical and cervical), without light emission (placebo).

    Drug: In-office dental bleaching · Drug: 5% potassium nitrate / 2% sodium fluoride gel

  • Experimental
    G4- KNO3 + LASER

    Group treated with desensitizing gel before bleaching and with LLLT after in-office bleaching.

    Drug: In-office dental bleaching · Drug: Low Level Laser Therapy · Drug: 5% potassium nitrate / 2% sodium fluoride gel

Interventions

  • DrugHydrogen PeroxideStudies of Hydrogen PeroxideHydrogen Peroxide pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    The group will receive in-office bleaching treatment. Three 15-minute applications of the 35% hydrogen peroxide gel were performed, totaling 45 minutes in each of the 3 sessions, with a 7-day interval.

    Also known as: 35% hydrogen peroxide

  • DrugLow Level Laser Therapy

    It will be used the infrared spectrum with wavelength of 808 nm in its active environment AsGaAl, in two points: cervical and apical region of the incisors, canines and premolars.

    Also known as: LLLT

  • Drug5% potassium nitrate / 2% sodium fluoride gel

    Drug pages: Potassium nitrateStudies of Potassium nitratePotassium nitrate pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · Sodium FluorideStudies of Sodium FluorideSodium Fluoride pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    5% potassium nitrate / 2% sodium fluoride gel will be applied for 10 minutes on the vestibular surface of all pre-bleached dental elements, following the manufacturer's protocol.

    Also known as: desensitizing therapy

06

What researchers measure

Primary outcomes

  1. Change in Stimulated pain intensity in different assessment times (P15)

    The stimulated pain intensity was self reported by the patients with a modified visual analog scale, from 0 to 3, where 0 means "no pain", 1 is "mild pain", 2 is "moderate pain" and 3 is "severe pain". For all groups, the patients evaluated the stimulated pain intensity two times per session: before and after the treatment in the same day. Thus, in total each patient reported the pain intensity 6 times, two times in the first day (1st session), two times in the eighth day (2nd session) and two times in the fifteenth day (3rd session).

    Time frame: 15 days, with assessments in the 1st, 8th and 15th day of the treatment

Secondary outcomes

  1. Non-stimulated pain intensity measure, (P21)

    Self reported non-stimulated pain intensity was assessed daily, during 21 days, through self-perception questionnaire, answered by the patients from the first tooth bleaching session until one week after the last session. The evaluation was performed by each patient, according to a modified visual analog scale, as follows: 0- no pain, 1 mild pain, 2 - moderate pain and 3 -severe pain

    Time frame: 21 days

07

Study locations

1 site
  • Brennda Lucy Freitas de Paula
    Belem, Para 66055-280, Brazil
08

References and documents

Publications

  • Reis A, Dalanhol AP, Cunha TS, Kossatz S, Loguercio AD. Assessment of tooth sensitivity using a desensitizer before light-activated bleaching. Oper Dent. 2011 Jan-Feb;36(1):12-7. doi: 10.2341/10-148-CR. Epub 2011 Mar 24. PubMed 21488723 ↗
  • Moosavi H, Arjmand N, Ahrari F, Zakeri M, Maleknejad F. Effect of low-level laser therapy on tooth sensitivity induced by in-office bleaching. Lasers Med Sci. 2016 May;31(4):713-9. doi: 10.1007/s10103-016-1913-z. Epub 2016 Mar 10. PubMed 26964798 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2017 to primary completion in Nov 2017, 7 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 16, 2018
First posted
Feb 15, 2018
StartActual
Apr 24, 2017
Primary completionActual
Nov 24, 2017
CompletionActual
Jan 15, 2018
Last update
Feb 15, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03434782
Lead sponsor
Universidade Federal do Para
Collaborators
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Responsible party
Cecy Martins Silva (Associate Professor, Universidade Federal do Para) — Principal investigator
First posted
Feb 15, 2018
Start date
Apr 24, 2017
Primary completion
Nov 24, 2017
Completion
Jan 15, 2018
Last update
Feb 15, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Potassium nitrate · Sodium Fluoride

Start the discussion